Abstract 4903: Multimodal therapy with a potent vaccine, metronomic cyclophosphamide and anti-PD-1 enhances immunotherapy of advanced tumors by increasing activation and clonal expansion of tumor infiltrating T cells

MLA

Neil L. Berinstein, et al. “Abstract 4903: Multimodal Therapy with a Potent Vaccine, Metronomic Cyclophosphamide and Anti-PD-1 Enhances Immunotherapy of Advanced Tumors by Increasing Activation and Clonal Expansion of Tumor Infiltrating T Cells.” Cancer Research, vol. 76, July 2016, p. 4903. EBSCOhost, https://doi.org/10.1158/1538-7445.am2016-4903.

APA

Neil L. Berinstein, Mohan Karkada, Tara Quinton, Genevieve Weir, Olga Hrytsenko, Marianne M. Stanford, & Marc Mansour. (2016). Abstract 4903: Multimodal therapy with a potent vaccine, metronomic cyclophosphamide and anti-PD-1 enhances immunotherapy of advanced tumors by increasing activation and clonal expansion of tumor infiltrating T cells. Cancer Research, 76, 4903. https://doi.org/10.1158/1538-7445.am2016-4903

Chicago

Neil L. Berinstein, Mohan Karkada, Tara Quinton, Genevieve Weir, Olga Hrytsenko, Marianne M. Stanford, and Marc Mansour. 2016. “Abstract 4903: Multimodal Therapy with a Potent Vaccine, Metronomic Cyclophosphamide and Anti-PD-1 Enhances Immunotherapy of Advanced Tumors by Increasing Activation and Clonal Expansion of Tumor Infiltrating T Cells.” Cancer Research 76 (July): 4903. doi:10.1158/1538-7445.am2016-4903.